31

Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Embed Size (px)

Citation preview

Page 1: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics
Page 2: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Publication Ethics

R.RaveendranChief Editor,

Journal of Pharmacology & Pharmacotherapeutics

Page 3: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Code of conduct for contributors to biomedical journals

Publication Ethics

Page 4: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Why should we bother?

“every single case of fraud and misconduct reduces public confidence, abuses the use of public and charitable funds and causes insult and frustration to the vast majority of careful and honest workers” (The Joint Consensus on Misconduct in Biomedical Research, Edinburgh 1999).

Page 5: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Is violation of publication ethics common?

Page 6: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Nature 435, 737-738 (9 June 2005)

Page 7: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Reasons for violating publication ethics

Unintentional IgnoranceGetting trapped

IntentionalPublish or Perish

Job Promotion Grant

Instant fame (followed by shame)

Page 8: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Unethical publication practices

Multiple submissionMultiple submission

Guest AuthorshipGuest Authorship

Fudging the content/dataFudging the content/data

Undeclared conflicts of interestUndeclared conflicts of interest

Redundant publicationRedundant publication

PlagiarismPlagiarism

Inappropriate acknowledgementsInappropriate acknowledgements

Page 9: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Manuscript SubmissionManuscript Submission

Don’t submit to more than one journal

at a time

Final version should have been read by

all the authors

Don’t submit without the

consent/knowledge of the co-author(s)

Page 10: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Authorship

not giving authorship to those who have made significant intellectual contribution.

giving authorship to those when they have NOT made significant intellectual contribution.

refusing to take public responsibility for the study or at least particular section of the study after the publication

Page 11: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Contents of manuscript

A manuscript must present the truth, nothing but the truth and the whole truth. intentionally hiding crucial information making false statements intentional alteration of data misquoting others work not quoting previous important works too many self citations publishing photographs of patients without consent not concealing the identity of patients (in the text as

well as the photographs)

Page 12: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Conflict of interestsConflict of interestsConflict of interest has been defined as

"a set of conditions in which professional judgment concerning a primary interest (such as patients' welfare or the validity of research) tends to be unduly influenced by a secondary interest (such as financial gain).“

It is a condition not a behavior, and there is nothing wrong with having a conflict of interest. It is common.

-BMJ

Page 13: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Conflict of interestsConflict of interests

commercial

political

personal

academic

Financial

Do NOT forget to declare competing interests

Page 14: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Redundant Publication(Duplicate Publication; Dual Publication)

Do not publish the same data/paper again and again

If you have to (!), inform the editors and take permission

Salami slicing?

Page 15: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Plagiarism Plagiarism is stealing others

ideas and contents of a paper (written or illustrative material) and passing it as ones own.

Copying large portions verbatim

from other papers is plagiarism even if references are given

Page 16: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

AcknowledgementsAcknowledgements

Acknowledge the funding / sponsoring agency

Don’t acknowledge routine work or duty

Acknowledging the Head of the Institution

Page 17: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

A faculty member in a medical college received an acknowledgement from a journal for submitting a research paper. The faculty member replied to the editor that she did not submit any paper and hence she cannot take any responsibility for the paper. It was found that her former student submitted the paper without her knowledge. The work was carried out in her lab and the student included her name as a corresponding author.

Page 18: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

A manuscript which was submitted to a journal was found to include a large chunk of data published already by the author in a journal. When asked, the author explained that he has used only a part of the data published already and added some new data to make one more manuscript.

Page 19: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

In a review submitted for publication, it was found that a few paragraphs were copied verbatim from another review published earlier in another journal. When the author was asked to explain, he said he had listed those articles under references and cited them in the running text and hence he can use the paragraphs word by word in his review.

Page 20: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

An author submitted a paper with partial data when whole data were available. After publication he submitted the entire data to the drug control authority with a conclusion different from the one he drew in the paper published in the journal.

Page 21: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

When a paper was about to be published, the authors wrote to the editor of IJP that he would like to withdraw the paper. The reason given was that he submitted the paper to another journal earlier but he did not hear from them for a long time. His reminding letters were not replied. Hence, he decided to submit the paper to the IJP but he subsequently found that the paper was published in the journal he first submitted and hence the withdrawal.

Page 22: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

A research work on usefulness of a particular type of exercise in patients with diabetes mellitus was submitted to journal. On finding no mention about the ethics committee permission, the editor of the journal asked for a clarification. The authors replied that they have taken informed consent from all and argued that since the study did not involve any intervention, there was no need for ethics committee permission.

Page 23: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

A paper published by a senior researcher contained fabricated data. When the editor asked the researcher she admitted the data were false but her junior did it without her knowledge. Her statement found to be true on enquiry.

Page 24: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

After the results of a clinical trial of a drug was published in a journal, a colleague of the authors wrote to the editor saying that the study was fully funded by a drug company but the information was not revealed in the paper.

Page 25: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

The number of original publications came out of from a college in the year 2011 was 107. More than 100 papers included the college principal as the last author. Almost every paper included the respective HoD as one of the authors.

Page 26: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

After a paper was published in a journal, the editor received a letter from two workers belonging to the dept from which the paper originated that the data published in the paper were collected by them in a field survey and they were not given authorship.

Page 27: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

Thank you

Page 28: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics
Page 29: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

http://www.wiley.com/bw/publicationethics/

Page 30: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

http://www.councilscienceedito

rs.org/

Page 31: Publication Ethics R.Raveendran Chief Editor, Journal of Pharmacology & Pharmacotherapeutics

http://publicationethics.org/